NCT05392881View on ClinicalTrials.gov

Interstitial Lung Disease Research Unit Biobank

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

August 1, 2031

Study Completion Date

March 1, 2032

Conditions
Interstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary FibrosisPulmonary FibrosisHypersensitivity Pneumonitis
Trial Locations (1)

66160

RECRUITING

The University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER